Oral and Topical Treatment of Painful Diabeti...

In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more abo ...  Show more

In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the 2026 A ...  Show more

[removed] ...

We are back with part 2 of our diabetes saga. Today, we discuss treatment goals and different oral agents that can be used to treat type 2 diabetes. Check out the website for the Rosh Review question of the week. Twitter: @creogsovercoff1 Instagram: @creogsovercoffee Facebook: ww ...  Show more

Dr. Howard Goodkin talks with Dr. Fred Lado about the National Association of Epilepsy Centers (NAEC) updated guidelines for specialized epilepsy centers.  Read the related article in Neurology. Disclosures can be found at Neurology.org. 

In this episode, Dr. Diane Reidy-Lagunes talks to pain management physician Dr. Neal Rakesh, and neurologist Dr. Anna DeForest, about the many options patients and doctors have to treat pain, including different therapies, safely managed painkillers, injections, and the possibili ...  Show more